Elanco
Update in progressELAN (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Elanco Animal Health develops, manufactures, and markets pet and farm animal health products worldwide. For pets, it offers parasiticides, vaccines, and therapeutics under brands such as Seresto, K-9 Advantage, Advantix, Advocate, Credelio, Interceptor Plus, Drontal, Galliprant, Atopica, Milbemax, Onsior, and TruFamily. For farm animals, it provides medicated feeds, injectables, vaccines, insecticides, and enzymes under brands like Rumensin, Baytril, Experior, Maxiban, Monteban, AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax. Sold via distributors, retailers, and directly to producers and veterinarians. Founded 1954, based in Indianapolis.
Company score
- Sentiment
- 0.90
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.43
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.51
- Governance
- -0.75
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.14
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.52
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Loading section